Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Receives FDA Fast Track Designation for Ebola Drug

Premium

Tekmira Pharmaceuticals this week announced that it has received a fast track designation for its phase I Ebola virus drug TKM-Ebola from the US Food and Drug Administration.

The designation is designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need, according to the FDA. The developers of eligible drugs may receive, among other things, more frequent meetings and correspondence with agency officials.

In January, Tekmira began testing TKM-Ebola in a phase I study. Data from the trial is expected in the second half of the year.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.